Utrecht Coronary Biobank (UCORBIO)

• Conditions: Coronary Artery Disease

• Registration Number: NCT02304744
• Lead Sponsor: UMC Utrecht

Brief Summary

UCORBIO enrolls patients who undergo coronary angiography (for any indication). The investigators draw blood at the moment of insertion of the procedural arterial catheter.

At the moment of inclusion indication, procedural details, risk factor status, medication use and quality of life (RAND-36 and EuroQoL) is assessed. Patients are then followed-up for the occurrence of major adverse cardiovascular events for 5 years. During the follow-up period patients receive a questionnaire every year to check for hospital admissions. The questionnaires at two and five years of follow-up are enriched with quality of life questionnaires (RAND-36 and EuroQoL).

Detailed Description

Not available

Study Timeline

• Study Start: 2011-10
• Study First Submitted: 2014-11-26
• Primary Completion: 2014-12
• Study First Submitted QC: 2014-12-01
• Study First Posted: 2014-12-02
• Status Verified: 2015-03
• Last Update Submitted: 2015-03-05
• Last Update Posted: 2015-03-06
• Study Completion: 2019-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 3000

Inclusion Criteria

• Coronary angiography

Exclusion Criteria

• Age < 18 years.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
major adverse cardiovascular events [MACE] (Stroke, myocardial infarction, coronary revascularization, death)	5 years	Stroke, myocardial infarction, coronary revascularization, death.

Trial Locations

Locations (1)

UMC Utrecht; 🇳🇱 Utrecht, Netherlands